"/> Novus Biologicals™ Peptide bloquant d’anticorps MY… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps MYOZAP

Réf. : BL-RE-085802Réf. fabricant : 18238875 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
100820829
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76547. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 18 amino acid peptide near the carboxy terminus of human MYOZAP.

Points forts

Source

Synthetic

(Accession #: NP_001018110) The MYOZAP Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-085802
Réf. fabricant18238875
Gene ID (Entrez)100820829
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76547. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneGCOM1, Gup, Gup1, Gup2, myocardial zonula adherens protein, MYOZAP, MYZAP
Symbole de gène(s)MYZAP
Type de produitMYOZAP
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne18 amino acid peptide near the carboxy terminus of human MYOZAP
Une question, une configuration particulière ?
Contactez-nous pour un devis.